Global Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report By Implantation Procedure (Transfemoral, Transapical, Transaortic), By Material (Nitinol, Cobalt Chromium, Stainless Steel, Others), By Mechanism (Balloon-expandable, Self-expandable), By End Use (Hospitals, Ambulatory Surgical Centers, Others), and Regional Forecasts 2022-2032
The global transcatheter aortic valve replacement (TAVR) market was valued at approximately USD 6.38 billion in 2023 and is projected to grow significantly at a compound annual growth rate (CAGR) of 6.6% from 2022 to 2032. This market growth is primarily driven by the increasing prevalence of aortic stenosis, the rising geriatric population, and the preference for minimally invasive procedures over traditional open-heart surgeries.
Aortic stenosis is a progressive cardiovascular condition characterized by the narrowing of the aortic valve, impeding blood flow. With the aging global population, the prevalence of this condition has surged. According to the World Health Organization, the population over 60 years old is projected to double by 2050, directly contributing to the demand for advanced cardiac interventions such as TAVR. Furthermore, TAVR's minimally invasive nature makes it a viable option for elderly patients or those with high surgical risk, further driving its adoption.
The market has also been significantly influenced by technological advancements. Continuous innovation in valve design, imaging techniques, and catheter technologies has improved procedural efficacy and patient outcomes. The launch of advanced devices such as Edwards Lifesciences’ Sapien 3 Ultra Resilia valve and Medtronic’s Evolut FX+ has set new benchmarks in safety, adaptability, and ease of use, expanding the patient pool for TAVR procedures.
Moreover, increasing investments and strategic partnerships in the healthcare sector have accelerated the development and adoption of TAVR systems. For instance, Sahajanand Medical Technologies’ launch of the Hydra TAVR system in Mexico highlights the global efforts to expand access to state-of-the-art cardiac treatments. These developments, coupled with favorable reimbursement policies in developed regions, bolster the market outlook.
Major Market Players Included in This Report Are:
By Implantation Procedure:
Aortic stenosis is a progressive cardiovascular condition characterized by the narrowing of the aortic valve, impeding blood flow. With the aging global population, the prevalence of this condition has surged. According to the World Health Organization, the population over 60 years old is projected to double by 2050, directly contributing to the demand for advanced cardiac interventions such as TAVR. Furthermore, TAVR's minimally invasive nature makes it a viable option for elderly patients or those with high surgical risk, further driving its adoption.
The market has also been significantly influenced by technological advancements. Continuous innovation in valve design, imaging techniques, and catheter technologies has improved procedural efficacy and patient outcomes. The launch of advanced devices such as Edwards Lifesciences’ Sapien 3 Ultra Resilia valve and Medtronic’s Evolut FX+ has set new benchmarks in safety, adaptability, and ease of use, expanding the patient pool for TAVR procedures.
Moreover, increasing investments and strategic partnerships in the healthcare sector have accelerated the development and adoption of TAVR systems. For instance, Sahajanand Medical Technologies’ launch of the Hydra TAVR system in Mexico highlights the global efforts to expand access to state-of-the-art cardiac treatments. These developments, coupled with favorable reimbursement policies in developed regions, bolster the market outlook.
Major Market Players Included in This Report Are:
- Medtronic plc
- Abbott Laboratories, Inc.
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- JenaValve Technology, Inc.
- Transcatheter Technologies GmbH
- Sahajanand Medical Technologies (SMT)
- Boston Scientific
- Terumo Corporation
- CryoLife, Inc.
- Direct Flow Medical, Inc.
- Micro Interventional Devices
By Implantation Procedure:
- Transfemoral
- Transapical
- Transaortic
- Nitinol
- Cobalt Chromium
- Stainless Steel
- Others
- Balloon-expandable
- Self-expandable
- Hospitals
- Ambulatory Surgical Centers
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Historical year: 2022
- Base year: 2023
- Forecast period: 2024-2032
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of the competitive structure of the market.
- Demand-side and supply-side analysis of the market.
CHAPTER 1. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET EXECUTIVE SUMMARY
1.1. Global Transcatheter Aortic Valve Replacement Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Implantation Procedure
1.3.2. By Material
1.3.3. By Mechanism
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising prevalence of aortic stenosis
3.1.2. Growing geriatric population
3.1.3. Increasing adoption of minimally invasive procedures
3.2. Market Challenges
3.2.1. High procedural costs
3.2.2. Regulatory hurdles
3.3. Market Opportunities
3.3.1. Technological advancements in TAVR systems
3.3.2. Expanding healthcare infrastructure in emerging markets
3.3.3. Rising demand for outpatient care
CHAPTER 4. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY IMPLANTATION PROCEDURE (2022-2032)
5.1. Segment Dashboard
5.2. Global Transcatheter Aortic Valve Replacement Market: Implantation Procedure Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Transfemoral
5.2.2. Transapical
5.2.3. Transaortic
CHAPTER 6. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY MATERIAL (2022-2032)
6.1. Segment Dashboard
6.2. Global Transcatheter Aortic Valve Replacement Market: Material Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Nitinol
6.2.2. Cobalt Chromium
6.2.3. Stainless Steel
6.2.4. Others
CHAPTER 7. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY MECHANISM (2022-2032)
7.1. Segment Dashboard
7.2. Global Transcatheter Aortic Valve Replacement Market: Mechanism Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Balloon-expandable
7.2.2. Self-expandable
CHAPTER 8. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY END USE (2022-2032)
8.1. Segment Dashboard
8.2. Global Transcatheter Aortic Valve Replacement Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Ambulatory Surgical Centers
8.2.3. Others
CHAPTER 9. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY REGION (2022-2032)
9.1. North America Transcatheter Aortic Valve Replacement Market
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe Transcatheter Aortic Valve Replacement Market
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Denmark
9.2.7. Sweden
9.2.8. Norway
9.3. Asia Pacific Transcatheter Aortic Valve Replacement Market
9.3.1. Japan
9.3.2. China
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Thailand
9.4. Latin America Transcatheter Aortic Valve Replacement Market
9.4.1. Brazil
9.4.2. Argentina
9.5. Middle East & Africa Transcatheter Aortic Valve Replacement Market
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Kuwait
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Medtronic plc
10.1.2. Abbott Laboratories, Inc.
10.1.3. Edwards Lifesciences Corporation
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Boston Scientific Corporation
10.3.2. Meril Life Sciences Pvt. Ltd.
10.3.3. JenaValve Technology, Inc.
10.3.4. Transcatheter Technologies GmbH
10.3.5. St. Jude Medical, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
1.1. Global Transcatheter Aortic Valve Replacement Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Implantation Procedure
1.3.2. By Material
1.3.3. By Mechanism
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising prevalence of aortic stenosis
3.1.2. Growing geriatric population
3.1.3. Increasing adoption of minimally invasive procedures
3.2. Market Challenges
3.2.1. High procedural costs
3.2.2. Regulatory hurdles
3.3. Market Opportunities
3.3.1. Technological advancements in TAVR systems
3.3.2. Expanding healthcare infrastructure in emerging markets
3.3.3. Rising demand for outpatient care
CHAPTER 4. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY IMPLANTATION PROCEDURE (2022-2032)
5.1. Segment Dashboard
5.2. Global Transcatheter Aortic Valve Replacement Market: Implantation Procedure Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Transfemoral
5.2.2. Transapical
5.2.3. Transaortic
CHAPTER 6. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY MATERIAL (2022-2032)
6.1. Segment Dashboard
6.2. Global Transcatheter Aortic Valve Replacement Market: Material Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Nitinol
6.2.2. Cobalt Chromium
6.2.3. Stainless Steel
6.2.4. Others
CHAPTER 7. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY MECHANISM (2022-2032)
7.1. Segment Dashboard
7.2. Global Transcatheter Aortic Valve Replacement Market: Mechanism Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Balloon-expandable
7.2.2. Self-expandable
CHAPTER 8. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY END USE (2022-2032)
8.1. Segment Dashboard
8.2. Global Transcatheter Aortic Valve Replacement Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Ambulatory Surgical Centers
8.2.3. Others
CHAPTER 9. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE & FORECASTS BY REGION (2022-2032)
9.1. North America Transcatheter Aortic Valve Replacement Market
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe Transcatheter Aortic Valve Replacement Market
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Denmark
9.2.7. Sweden
9.2.8. Norway
9.3. Asia Pacific Transcatheter Aortic Valve Replacement Market
9.3.1. Japan
9.3.2. China
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Thailand
9.4. Latin America Transcatheter Aortic Valve Replacement Market
9.4.1. Brazil
9.4.2. Argentina
9.5. Middle East & Africa Transcatheter Aortic Valve Replacement Market
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Kuwait
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Medtronic plc
10.1.2. Abbott Laboratories, Inc.
10.1.3. Edwards Lifesciences Corporation
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Boston Scientific Corporation
10.3.2. Meril Life Sciences Pvt. Ltd.
10.3.3. JenaValve Technology, Inc.
10.3.4. Transcatheter Technologies GmbH
10.3.5. St. Jude Medical, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
